Back to Awarded Treatment Trials


Awarded Trial: 02T-132

Grant ID

02T-132

Illness

Schizophrenia

Primary Drug/Intervention

Mifepristone

Primary Dosage

800 mg/day

Secondary Drug Intervention

Haloperidol

Secondary Dosage

10 mg/day

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Terminated

Investigator

Verdoux

Sample Size

80

Duration of Study Period for Each Subject

4 weeks

Outcome Measurements

PANSS, CGI, Simpson-Angus Scale

Results

Study terminated in August 2003 due to poor enrollment.

Publication

N/A

Link

N/A

PI Name

Helene Verdoux

Degree

MD

Center

Association pour la Recherche Medicale en Aquitaine (ARMA)

Institution

University Victor Segalen Bordeaux 2

Address

146, rue Leo Saignat

City or Town

Bordeaux

State or Province

N/A

Zip or Postal Code

33076

Country

France

Email Address

helene.verdoux@perrens.aquisante.fr